Literature DB >> 27916272

Regulation and function of anaphylatoxins and their receptors in allergic asthma.

Yves Laumonnier1, Anna V Wiese2, Julia Figge2, Christian Karsten3.   

Abstract

Allergic asthma is a disease of the airways driven by maladaptive T helper 2 (Th2) and Th17 immune response against harmless, airborne substances. The hallmarks of this disease are airway hyperresponsiveness (AHR), eosinophilic and neutrophilic airway inflammation and mucus overproduction. Distinct dendric cell (DC) subsets together with airway epithelial and pulmonary vascular endothelial cells play critical roles in allergen sensing and in driving T cell differentiation towards Th2 and Th17 effector or regulatory T cells (Treg). Previous studies suggested already a pivotal role for the anaphylatoxins (C5a, C3a) in the pathogenesis of allergic asthma. During sensitization for example it is described, that C3a promotes, whereas C5a protects from the development of maladaptive immunity during allergen sensitization. Here we will discuss the role of the anaphylatoxins (C3a, C5a) and their receptors during the pathogenesis of allergic asthma, and specifically in lung DC biology. We will also have a look on canonical and non-canonical complement activation and we will discuss novel concepts on how the adaptive immune system can regulate the function of ATRs also in the context of allergic asthma.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Allergic asthma; Anaphylatoxins; Dendritic cells; Immune complexes

Mesh:

Substances:

Year:  2017        PMID: 27916272     DOI: 10.1016/j.molimm.2016.11.013

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  4 in total

1.  Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions.

Authors:  Laura Brandolini; Michele d'Angelo; Rubina Novelli; Vanessa Castelli; Cristina Giorgio; Anna Sirico; Pasquale Cocchiaro; Francesco D'Egidio; Elisabetta Benedetti; Claudia Cristiano; Antonella Bugatti; Anna Ruocco; Pier Giorgio Amendola; Carmine Talarico; Candida Manelfi; Daniela Iaconis; Andrea Beccari; Andreza U Quadros; Thiago M Cunha; Arnaldo Caruso; Roberto Russo; Annamaria Cimini; Andrea Aramini; Marcello Allegretti
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

2.  The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.

Authors:  Anna V Wiese; Fanny Ender; Katharina M Quell; Konstantina Antoniou; Tillman Vollbrandt; Peter König; Jörg Köhl; Yves Laumonnier
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

3.  C3a signaling is not involved in eosinophil migration during experimental allergic lung inflammation in mice.

Authors:  Jack Yang; Cornelis Van't Veer; Marieke S Ten Brink; Alex F de Vos; Tom van der Poll
Journal:  Allergy       Date:  2019-09-03       Impact factor: 13.146

4.  Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.

Authors:  Peter W West; Rajia Bahri; Karen M Garcia-Rodriguez; Georgia Sweetland; Georgia Wileman; Rajesh Shah; Angeles Montero; Laura Rapley; Silvia Bulfone-Paus
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.